Guardant in the News
Precision Medicine is Transforming Cancer Care
How sophisticated technology and personalized treatment options are enabling more people with advanced cancer to manage and live with their diagnoses for the long-term.
Using Data to Conquer Cancer
Helmy Eltoukhy stops by The Morning Fix by 510k Café podcast to discuss the technologies Guardant Health is developing for patients with early and late-stage cancers. We also discuss the Clear Your View campaign, which raises awareness of the essential role complete biomarker testing plays in guiding initial treatment decisions for patients with advanced solid tumor cancers, including colorectal and lung cancers.
The Promise of Cancer Screening: Screen for Cancers Where Lives Can be Saved
Innovations in cancer therapeutics and precision diagnostics impact countless lives as more and more cancer patients are able to claim the title of cancer survivor. While we applaud this progress, for too many patients innovation has not won out over disease.
Disparities in clinical trials threaten African American lives
On World Cancer Research Day, we must correct course
Craig Eagle of Guardant Health: In Light Of The Pandemic, Here Are The 5 Things We Need To Do To Improve The US Healthcare System
Place greater focus on healthcare equity — COVID-19 was a reminder of how disease disproportionately impacts certain groups, including people of color and lower socioeconomic status. Unfortunately, cancer, which remains a leading killer of Americans, is no different. We must continue to promote more equitable access to healthcare and the latest advancements, including easier-to-perform tests like liquid biopsy, to help democratize cancer testing and make the best treatments accessible to all people.
Doctors Predict Post-Pandemic Spike in Advanced Cancers: It’s Time to Adopt New Life-Saving…
At the onset of COVID-19, stay-at-home orders were necessary to address an acute public health problem. But the shutdowns had unintended consequences across other areas of healthcare.
The Top 50 Healthcare Technology CEOs Of 2021
The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2021. This year’s awardees represent some of the most accomplished executives in healthcare technology.
Discussing the Pivotal Role Biomarker Testing Plays in Treatment of Lung Cancer Patients
Worldwide, lung cancer is the leading cause of cancer death,1 and in the U.S., more than 235,000 people will be diagnosed with lung cancer this year.2 Non-small cell lung cancer (NSCLC) is a devastating disease that accounts for 84% of all lung cancer diagnoses.2
Catching cancer extremely early
Better, faster, and earlier: Cancer screening has come of age, with many methods capable of testing multiple cancers in one sample.
We Must Implement Covid Relief Because Cancer Doesn’t Wait
Two weeks ago, I was proud to join more than 150 business leaders in signing a letter urging Congress to swiftly adopt a COVID-19 stimulus and relief plan. Today, I am thrilled that the American Rescue Plan has been signed into law by President Joe Biden. This relief package is a significant and necessary step in the fight against COVID that will invigorate the public health response to the crisis and support desperately needed vaccination efforts.